FDA to Hold Workshop on Kidney Transplant Issues

The FDA will hold a public workshop June 28 and 29 on the clinical development of devices, drugs and biologics for prophylaxis or treatment of acute mediated rejection in kidney transplant recipients. The workshop will be held at the Crowne Plaza Hotel in Silver Spring, Md. Registration is on a first-come basis.